Research letter
Effectiveness and safety of low-dose oral minoxidil in male androgenetic alopecia

https://doi.org/10.1016/j.jaad.2019.04.054Get rights and content

References (4)

  • R.A. Beach

    Case series of oral minoxidil for androgenetic and traction alopecia: tolerability & the five C's of oral therapy

    Dermatol Ther

    (2018)
  • R.D. Sinclair

    Female pattern hair loss: a pilot study investigating combination therapy with low-dose oral minoxidil and spironolactone

    Int J Dermatol

    (2018)
There are more references available in the full text version of this article.

Cited by (67)

  • Androgenetic alopecia in transgender and gender diverse populations: A review of therapeutics

    2023, Journal of the American Academy of Dermatology
    Citation Excerpt :

    A multicenter retrospective study (n = 1404 cisgender men and women) demonstrated that LDOM has a good safety profile.23 Side effects include dizziness and postural hypotension (Table II).17-19,21,23,24-27,32-35,38,39,42,46,48,50-52 Hypertrichosis is most common, especially at 5 mg daily, but generally mild and may be less concerning in transmasculine patients, depending on desired gender expression.18,21,23,51

View all citing articles on Scopus

Funding sources: None.

Conflicts of interest: None disclosed.

View full text